Considering the abovementioned human data [66] and our observations in the Tg2576 animal model, we speculate that IP-10 levels may be elevated during the early stages AD pathogenesis, yet reduced in advanced disease. This evidence concerns the gene CXCL10 and Alzheimer disease.